elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46738588-56C1F8EF-054D-44A9-8E3A-BCB1A7218DB2
Q46738588-56C1F8EF-054D-44A9-8E3A-BCB1A7218DB2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46738588-56C1F8EF-054D-44A9-8E3A-BCB1A7218DB2
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
P2860
Q46738588-56C1F8EF-054D-44A9-8E3A-BCB1A7218DB2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46738588-56C1F8EF-054D-44A9-8E3A-BCB1A7218DB2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd6a91ea349cb9e7ca8bbe4b9dd319f65e5c37a4
P2860
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.